Innate resistance to flavivirus infections and the functions of 2′-5′ oligoadenylate synthetases

Current Topics in Microbiology and Immunology

Volumn 321, Issue , 2008, Pages 85-100

  Mashimo, T ^a   Simon Chazottes, D ^b   Guenet J L ^b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2' OLIGOADENYLATE SYNTHETASE; 3' OLIGOADENYLATE SYNTHETASE; 4' OLIGOADENYLATE SYNTHETASE; 5' OLIGOADENYLATE SYNTHETASE; SYNTHETASE; UNCLASSIFIED DRUG; 2',5' OLIGOADENYLATE SYNTHETASE;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; APOPTOSIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CLUSTER ANALYSIS; DNA SEQUENCE; EVOLUTION; FLAVIVIRUS; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE SEQUENCE; GENE STRUCTURE; GENETIC POLYMORPHISM; GENETIC RESISTANCE; HUMAN; INFECTION RESISTANCE; INFECTION SENSITIVITY; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MAMMAL; MOLECULAR CLONING; MOLECULAR EVOLUTION; MULTIGENE FAMILY; MULTIPLE SCLEROSIS; NONHUMAN; NONSENSE MUTATION; PATHOGENICITY; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOGENE; REVIEW; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS INFECTION; WEST NILE FLAVIVIRUS; ANIMAL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MOUSE; PHYSIOLOGY;

FLAVIVIRUS; MAMMALIA; WEST NILE VIRUS;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; FLAVIVIRUS INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, NATURAL; MICE;

EID: 51149092092     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-75203-5_4     Document Type: Review

References (47)

1. Bonnevie-Nielsen V, Field LL, Lu S, Zheng DJ, Li M, Martensen PM, Nielsen TB, Beck-Nielsen H, Lau YL, Pociot F (2005) Variation in antiviral 2′,5′-oligoadenylate synthetase (2′5′AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am J Hum Genet 76:623-633
2. Brinton MA, Perelygin AA (2003) Genetic resistance to flaviviruses. Adv Virus Res 60:43-85
3. Cayley PJ, White RF, Antoniw JF, Walesby NJ, Kerr IM (1982) Distribution of the ppp(A2′p)nA-binding protein and interferon-related enzymes in animals, plants, and lower organisms. Biochem Biophys Res Commun 108:1243-1250
4. Cheng G, Nazar AS, Shin HS, Vanguri P, Shin ML (1998) IP-10 gene transcription by virus in astrocytes requires cooperation of ISRE with adjacent kappaB site but not IRF-1 or viral transcription. J Interferon Cytokine Res 18:987-997
5. Eldadah AH, Nathanson N, Sarsitis R (1967) Pathogenesis of West Nile virus encephalitis in mice and rats. 1. Influence of age and species on mortality and infection. Am J Epidemiol 86:765-775
6. Eskildsen S, Hartmann R, Kjeldgaard NO, Justesen J (2002) Gene structure of the murine 2′-5′-oligoadenylate synthetase family. Cell Mol Life Sci 59:1212-1222
7. Fedetz M, Matesanz F, Caro-Maldonado A, Fernandez O, Tamayo JA, Guerrero M, Delgado C, Lopez-Guerrero JA, Alcina A (2006) OAS1 gene haplotype confers susceptibility to multiple sclerosis. Tissue Antigens 68:446-449
8. Field LL, Bonnevie-Nielsen V, Pociot F, Lu S, Nielsen TB, Beck-Nielsen H (2005) OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. Diabetes 54:1588-1591
9. Ghosh A, Sarkar SN, Guo W, Bandyopadhyay S, Sen GC (1997) Enzymatic activity of 2′-5′-oligoadenylate synthetase is impaired by specific mutations that affect oligomerization of the protein. J Biol Chem 272:33220-33226
10. Godfrey PA, Malnic B, Buck LB (2004) The mouse olfactory receptor gene family. Proc Natl Acad Sci U S A 101:2156-2161
11. Haller O, Frese M, Kochs G (1998) Mx proteins: mediators of innate resistance to RNA viruses. Rev Sci Tech 17:220-230
12. Hamano E, Hijikata M, Itoyama S, Quy T, Phi NC, Long HT, Ha le D, Ban VV, Matsushita I, Yanai H, Kirikae F, Kirikae T, Kuratsuji T, Sasazuki T, Keicho N (2005) Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. Biochem Biophys Res Commun 329:1234-1239
13. Hartmann R, Olsen HS, Widder S, Jorgensen R, Justesen J (1998) p59OASL, a 2′-5′ oligoadenylate synthetase like protein: a novel human gene related to the 2′-5′ oligoadenylate synthetase family. Nucleic Acids Res 26:4121-4128
14. Hartmann R, Justesen J, Sarkar SN, Sen GC, Yee VC (2003) Crystal structure of the 2′-specific and double-stranded RNA-activated interferon-induced antiviral protein 2′-5′-oligoadenylate synthetase. Mol Cell 12:1173-1185
15. He J, Feng D, de Vlas SJ, Wang H, Fontanet A, Zhang P, Plancoulaine S, Tang F, Zhan L, Yang H, Wang T, Richardus JH, Habbema JD, Cao W (2006) Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study. BMC Infect Dis 6:106
16. Honda A, Takahashi H, Toguri T, Ogawa T, Hase S, Ikegami M, Ehara Y (2003) Activation of defense-related gene expression and systemic acquired resistance in cucumber mosaic virus-infected tobacco plants expressing the mammalian 2′5′oligoadenylate system. Arch Virol 148:1017-1026
17. Hovanessian AG, Justesen J (2007) The human 2′- 5′oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation. Biochimie 89:779-788
18. Hovnanian A, Rebouillat D, Mattei MG, Levy ER, Marie I, Monaco AP, Hovanessian AG (1998) The human 2′,5′-oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100-, 69-, and 40-kDa forms. Genomics 52:267-277
19. Justesen J, Hartmann R, Kjeldgaard NO (2000) Gene structure and function of the 2′-5′-oligoadenylate synthetase family. Cell Mol Life Sci 57:1593-1612
20. Kajaste-Rudnitski A, Mashimo T, Frenkiel MP, Guenet JL, Lucas M, Despres P (2006) The 2′,5′-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells. J Biol Chem 281:4624-4637
21. Kakuta S, Shibata S, Iwakura Y (2002) Genomic structure of the mouse 2′,5′-oligoadenylate synthetase gene family. J Interferon Cytokine Res 22:981-993
22. Knapp S, Yee LJ, Frodsham AJ, Hennig BJ, Hellier S, Zhang L, Wright M, Chiaramonte M, Graves M, Thomas HC, Hill AV, Thursz MR (2003) Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun 4:411-419
23. Lengeling A, Pfeffer K, Balling R (2001) The battle of two genomes: genetics of bacterial host/pathogen interactions in mice. Mamm Genome 12:261-271
24. Lucas M, Mashimo T, Frenkiel MP, Simon-Chazottes D, Montagutelli X, Ceccaldi PE, Guenet JL, Despres P (2003) Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2′-5′ oligoadenylate synthetase 1b protein. Immunol Cell Biol 81:230-236
25. Mashimo T, Lucas M, Simon-Chazottes D, Frenkiel MP, Montagutelli X, Ceccaldi PE, Deubel V, Guenet JL, Despres P (2002) A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci U S A 99:11311-11316
26. Mashimo T, Glaser P, Lucas M, Simon-Chazottes D, Ceccaldi PE, Montagutelli X, Despres P, Guenet JL (2003) Structural and functional genomics and evolutionary relationships in the cluster of genes encoding murine 2′,5′0-oligoadenylate synthetases. Genomics 82:537-552
27. Mitra A, Higgins DW, Langenberg WG, Nie H, Sengupta DN, Silverman RH (1996) A mammalian 2-5A system functions as an antiviral pathway in transgenic plants. Proc Natl Acad Sci U S A 93:6780-6785
28. Ogawa T, Hori T, Ishida I (1996) Virus-induced cell death in plants expressing the mammalian 2′,5′ oligoadenylate system. Nat Biotechnol 14:1566-1569
29. Perelygin AA, Scherbik SV, Zhulin IB, Stockman BM, Li Y, Brinton MA (2002) Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci U S A 99:9322-9327
30. Perelygin AA, Lear TL, Zharkikh AA, Brinton MA (2005) Structure of equine 2′-5′oligoadenylate synthetase (OAS) gene family and FISH mapping of OAS genes to ECA8p15→p14 and BTA17q24→q25. Cytogenet Genome Res 111:51-56
31. Perelygin AA, Zharkikh AA, Scherbik SV, Brinton MA (2006) The mammalian 2′-5′ oligoadenylate synthetase gene family: evidence for concerted evolution of paralogous Oas1 genes in Rodentia and Artiodactyla. J Mol Evol 63:562-576
32. Rebouillat D, Hovanessian AG (1999) The human 2′,5′- oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J Interferon Cytokine Res 19:295-308
33. Rebouillat D, Marie I, Hovanessian AG (1998) Molecular cloning and characterization of two related and interferon-induced 56-kDa and 30-kDa proteins highly similar to 2′-5′ oligoadenylate synthetase. Eur J Biochem 257:319-330
34. Sarkar SN, Ghosh A, Wang HW, Sung SS, Sen GC (1999) The nature of the catalytic domain of 2′-5′-oligoadenylate synthetases. J Biol Chem 274:25535-25542
35. Scherbik SV, Paranjape JM, Stockman BM, Silverman RH, Brinton MA (2006) RNase L plays a role in the antiviral response to West Nile virus. J Virol 80:2987-2999
36. Scherbik SV, Kluetzman K, Perelygin AA, Brinton MA (2007) Knock-in of the Oas1br allele into a flavivirus-induced disease susceptible mouse generates the resistant phenotype. Virology 368:232-237
37. Shibata S, Kakuta S, Hamada K, Sokawa Y, Iwakura Y (2001) Cloning of a novel 2′,5′-oligoadenylate synthetase-like molecule, Oasl5 in mice. Gene 271:261-271
38. Smyth DJ, Cooper JD, Lowe CE, Nutland S, Walker NM, Clayton DG, Todd JA (2006) No evidence for association of OAS1 with type 1 diabetes in unaffected siblings or type 1 diabetic cases. Diabetes 55:1525-1528
39. Staeheli P, Danielson P, Haller O, Sutcliffe JG (1986) Transcriptional activation of the mouse Mx gene by type I interferon. Mol Cell Biol 6:4770-4774
40. Tessier MC, Qu HQ, Frechette R, Bacot F, Grabs R, Taback SP, Lawson ML, Kirsch SE, Hudson TJ, Polychronakos C (2006) Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype? J Med Genet 43:129-132
41. Torshin IY (2005) Three-dimensional models of human 2′-5′ oligoadenylate synthetases: a new computational method for reconstructing an enzyme assembly. Med Sci Monit 11:BR235-247
42. Urosevic N, Silvia OJ, Sangster MY, Mansfield JP, Hodgetts SI, Shellam GR (1999) Development and characterization of new flavivirus-resistant mouse strains bearing Flv(r)-like and Flv(mr) alleles from wild or wild-derived mice. J Gen Virol 80:897-906
43. Wade CM, Kulbokas EJ 3rd, Kirby AW, Zody MC, Mullikin JC, Lander ES, Lindblad-Toh K, Daly MJ (2002) The mosaic structure of variation in the laboratory mouse genome. Nature 420:574-578
44. Wiens M, Kuusksalu A, Kelve M, Muller WE (1999) Origin of the interferon-inducible (2′-5′)oligoadenylate synthetases: cloning of the (2′-5′)oligoadenylate synthetase from the marine sponge Geodia cydonium. FEBS Lett 462:12-18
45. Yakub I, Lillibridge KM, Moran A, Gonzalez OY, Belmont J, Gibbs RA, Tweardy DJ (2005) Single nucleotide polymorphisms in genes for 2′-5′-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J Infect Dis 192:1741-1748
46. Yamamoto A, Iwata A, Koh Y, Kawai S, Murayama S, Hamada K, Maekawa S, Ueda S, Sokawa Y (1998) Two types of chicken 2′,5′-oligoadenylate synthetase mRNA derived from alleles at a single locus. Biochim Biophys Acta 1395:181-191
47. Yan W, Ma L, Stein P, Pangas SA, Burns KH, Bai Y, Schultz RM, Matzuk MM (2005) Mice deficient in oocyte-specific oligoadenylate synthetase-like protein OAS1D display reduced fertility. Mol Cell Biol 25:4615-4624